In 2023, the value of respiratory system medicine sales in Japan stood at 970 million US dollars PPP. The forecasted data from 2024 to 2028 show a consistent year-on-year decrease in sales value. The sales values decrease from 957 million USD in 2024 to 904.5 million USD in 2028. The compound annual growth rate (CAGR) over the five-year period indicates an average annual decline of approximately 1.4%.

Future trends to watch for:

Technological advancements in respiratory medicine which could alter market dynamics.
Changes in regulatory policies affecting market access and drug pricing.
Impact of emerging respiratory diseases and the potential for increased demand.
Demographic shifts such as an aging population which may influence the overall market needs.